Home 5 Lab Industry Report 5 Industry Buzz-lir 5 Medicare Reimbursement: 4 Molecular Assays Score Big Coverage Wins

Medicare Reimbursement: 4 Molecular Assays Score Big Coverage Wins

by | Sep 29, 2017

Molecular labs continue to gain ground with Medicare securing four key approvals via finalization of Local Coverage Determinations (LCDs) issued by principal contractor Palmetto GBA this spring. All of the determinations take effect Oct. 9. 1. Oncotype DX for Intermediate-Risk Prostate Cancer Test: Genomic Health’s Oncotype DX Genomic Prostate Score (GPS) for prostate cancer risk […]

Molecular labs continue to gain ground with Medicare securing four key approvals via finalization of Local Coverage Determinations (LCDs) issued by principal contractor Palmetto GBA this spring. All of the determinations take effect Oct. 9. 1. Oncotype DX for Intermediate-Risk Prostate Cancer Test: Genomic Health’s Oncotype DX Genomic Prostate Score (GPS) for prostate cancer risk […]

This content is Exclusive to Lab Industry Report Subscribers

Subscribe or Log in for Exclusive Access.